Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 5.06% | $246.26K | $283.39B | 35.02% | 79 Outperform | |
| HOYA | 4.89% | $237.73K | ¥7.90T | 19.46% | 68 Neutral | |
| ASML Holding NV | 4.65% | $226.46K | €353.99B | 39.54% | 76 Outperform | |
| Mercadolibre | 4.34% | $211.32K | $104.67B | 5.74% | 71 Outperform | |
| Nomura Research Institute | 4.21% | $205.02K | ¥3.57T | 23.77% | 74 Outperform | |
| Ferrari | 3.95% | $192.42K | $92.09B | -11.54% | 72 Outperform | |
| ― | 3.79% | $184.45K | ― | ― | ― | |
| Air Liquide | 3.62% | $176.30K | €95.79B | 5.05% | 66 Neutral | |
| Sea | 3.62% | $176.26K | $80.09B | 19.46% | 69 Neutral | |
| Lonza Group Ltd | 3.31% | $160.97K | CHF37.93B | 4.99% | 71 Outperform |